MK-677 does not suppress the HPA axis, does not raise cortisol or prolactin at standard doses, and has no documented hepatotoxicity
International clinical psychopharmacology, 18(2), 6171
AAX Biotech AB has entered a collaboration with global ADC leader Daiichi Sankyo to explore the potential of its Opti-mAb platform
If you are considering Retatrutide, ask a qualified clinician how current regulatory status affects safety, monitoring, and whether any access path is appropriate for your situation
Disorganized gyrification network properties during the transition to psychosis
This peptide helps reduce inflammation and supports long-term joint health, without relying on NSAIDs or steroid injections